Published on Friday January 06, 2023

We are working on the following new projects:

  • We were awarded with a bioequivalence trial of Ketorolac.
  • We are signing contracts for bioequivalence trials with Glecaprevir+Pibrentasvir and Sofosbuvir.
  • Smooth signed a contract for medical writing in BE trials with Rivaroxaban 2,5 mg, 10 mg and 20 mg.

We are happy to reach the following milestones in our projects:

  • A clinical part was finished in the Nimesulide trial with dorsopathy.
  • 7 subjects were randomized in India and 28 in Russia in the international phase III clinical trial of the original drug for the patients with chronic myeloid leukemia.
  • 185 subjects were included in the phase III trial with postoperative pain.